ORGS Market Cap History



Below is a table of the ORGS market cap history going back to 11/16/2017:

Date ORGS Market Cap
11/16/201730.44M
2/28/201881.16M
3/13/2018114.86M
4/16/2018110.06M
7/16/2018119.76M
10/12/201898.88M
2/13/201976.07M
5/8/201972.52M
8/8/201975.38M
12/6/20135.94M
11/7/201956.24M
3/9/202067.94M
5/8/2020134.40M
8/6/2020120.64M
11/5/2020112.33M
3/9/2021181.74M
5/6/2021111.38M
8/5/2021129.56M
11/4/2021112.15M
3/30/202284.14M
5/23/202252.12M
8/15/202247.77M
11/10/202236.53M
3/22/202336.84M
8/10/202328.18M
11/13/202317.85M

Also see: ORGS Shares Outstanding History
and ORGS YTD Return
ORGS Historical Market Cap:
-8.52% CAGR
ORGS Historical Market Cap: +-8.52% CAGR

Mouse over chart for data details
11/16/2017 ...11/13/2023
Orgenesis is a global biotech company working to unlock the potential of cell and gene therapies (CGTs). CGTs can be centered on autologous (using the patient's own cells) or allogenic (using master banked donor cells) and are part of a class of medicines referred to as advanced therapy medicinal products. Co. is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care. We show 26 historical shares outstanding datapoints in our ORGS shares outstanding history coverage, used to compute ORGS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ORGS market cap history over the course of time is important for investors interested in comparing ORGS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ORGS versus a peer is one thing; comparing ORGS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ORGS can fluctuate over the course of history. With this page we aim to empower investors researching ORGS by allowing them to research the ORGS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ORGS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Orgenesis (ORGS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ORIC Market Cap History
ORMP Market Cap History
OSA Market Cap History
OSH Market Cap History
OSIR Market Cap History
OSUR Market Cap History
OTIC Market Cap History
OTLK Market Cap History
OTRK Market Cap History
OVAS Market Cap History
More Healthcare companies »

 

ORGS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.